
Kistler to showcase how digital meets circular economy at Fakuma 2023
Aug 30, 2023How to improve the surface quality of automotive moulds?
Aug 20, 2023Fully recyclable fiber composite plastics for the circular economy
Aug 07, 2023Common Manufacturing Product Development Challenges
Jul 28, 2023Fu Yu breaks the mould, redefines precision plastic manufacturing with sustainability
Aug 29, 2023Phillips
Posted by Staff | Aug 17, 2023
Phillips-Medisize, a Molex company, has entered into a collaborative agreement with Modular Medical, a development stage insulin-delivery technology firm. Phillips-Medisize is bringing its design and development expertise to the manufacture and assembly of the MODD1 insulin-delivery system, which Modular Medical describes as the “next generation of user-friendly and affordable insulin pump technology.”
San Diego-based Modular Medical has developed proprietary technologies that are said to eliminate the trade off between complexity and efficacy, "thereby making top-quality insulin-delivery both affordable and simple to learn." The company was founded by Paul DiPerna, a medical device professional and microfluidics engineer who invented and designed the t:slim insulin pump, marketed through Tandem Diabetes, which he established in 2005.
Phillips-Medisize has a long history of designing, engineering, and manufacturing drug delivery, in-vitro diagnostic, medtech, and specialty consumer devices. Specific expertise provided to Medical Modular includes conventional, two-shot, and insert injection molding, as well as other services such as packaging, electronics design and manufacturing, and assembly operations. Headquartered in Hudson, WI, the contract services company operates multiple facilities throughout North America, Europe, and Asia.
"This collaboration has provided Modular Medical with an accelerated development process, while simultaneously preparing for significant scalability and market launch readiness," said Kevin Schmid, COO of Modular Medical. "Phillips-Medisize brought engineering resources, insulin delivery materials, and medical manufacturing knowledge, while providing supply chain expertise, to enable Modular Medical to scale rapidly and seamlessly to meet anticipated consumer demand. The collaboration is preparing Modular Medical to quickly market its new delivery technology for insulin-requiring patients with diabetes," said Schmid.
More information about text formats
Environmental concerns about plastics are valid, but politicians and corporations often cow to activists without considering that they can be a sustainable choice in many applications.We're tracking the industry's fight to ensure common sense prevails.

